Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LONP1 | P36776 | 13/20 | 0.68 |
| ▸ | PSMB5 | P28074 | 11/20 | 0.68 |
| ▸ | PSMB8 | P28062 | 10/20 | 0.68 |
| ▸ | PSMB9 | P28065 | 10/20 | 0.68 |
| ▸ | PSMB6 | P28072 | 10/20 | 0.68 |
| ▸ | PSMB10 | P40306 | 10/20 | 0.68 |
| ▸ | PSMB11 | A5LHX3 | 9/20 | 0.68 |
| ▸ | PSMA7 | O14818 | 9/20 | 0.68 |
| ▸ | PSMB1 | P20618 | 9/20 | 0.68 |
| ▸ | PSMA1 | P25786 | 9/20 | 0.68 |
| ▸ | PSMA2 | P25787 | 9/20 | 0.68 |
| ▸ | PSMA3 | P25788 | 9/20 | 0.68 |
| ▸ | PSMA4 | P25789 | 9/20 | 0.68 |
| ▸ | PSMA5 | P28066 | 9/20 | 0.68 |
| ▸ | PSMB4 | P28070 | 9/20 | 0.68 |
| ▸ | PSMB3 | P49720 | 9/20 | 0.68 |
| ▸ | PSMB2 | P49721 | 9/20 | 0.68 |
| ▸ | PSMA6 | P60900 | 9/20 | 0.68 |
| ▸ | PSMA8 | Q8TAA3 | 9/20 | 0.68 |
| ▸ | PSMB7 | Q99436 | 9/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL680573 | 1.00 | LONP1 (0.68) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL13078869 | 0.90 | CTSL (0.71) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL535688 | 0.90 | LONP1 (0.71) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL535687 | 0.90 | LONP1 (0.71) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL3926604 | 0.88 | LONP1 (0.69) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL12521571 | 0.87 | PSMB5 (0.74) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL3926607 | 0.86 | LONP1 (0.67) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL25003548 | 0.85 | CTSL (0.69) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL3083268 | 0.85 | CTSL (0.69) | LONP1PSMB5PSMB8PSMB9PSMB6 | |
| SCHEMBL25110920 | 0.85 | LONP1 (0.72) | LONP1PSMB5PSMB8PSMB9PSMB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083760-A1 | STABLE LIQUID BORTEZOMIB FORMULATIONS | Riconpharma LLC (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2023078464-A1 | EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | 上海弼领生物技术有限公司 | 2023-05-11 | — | — | WO | disclosed |
| US-20220133757-A1 | AQUEOUS COMPOSITIONS OF BORTEZOMIB | SPES PHARMACEUTICALS INC. | 2022-05-05 | — | — | US | disclosed |
| CN-110312727-A | A kind of improved method for preparing borate | 费森尤斯卡比肿瘤学有限公司 | 2019-10-08 | — | — | CN | disclosed |
| WO-2019151133-A1 | MANUFACTURING METHOD FOR BORTEZOMIB CRYSTALS | 日本化薬株式会社 | 2019-08-08 | — | — | WO | disclosed |
| WO-2018092724-A1 | MOLECULAR KINETICS EVALUATION METHOD AND SCREENING METHOD | 学校法人東京理科大学 | 2018-05-24 | — | — | WO | disclosed |
| WO-2018092723-A1 | Ras PROTEIN DEGRADATION INDUCING MOLECULE AND PHARMACEUTICAL COMPOSITION | 学校法人東京理科大学 | 2018-05-24 | — | — | WO | disclosed |
| WO-2012047845-A1 | BORTEZOMIB FORMULATIONS STABILISED WITH BORIC | APP PHARMACEUTICALS (US) | 2012-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083760-A1 | STABLE LIQUID BORTEZOMIB FORMULATIONS | BCL6, BCL9, PSMD2 | LONP1 2613/4885PSMB5 21/4885PSMB8 37/4885 |
| US-20220133757-A1 | AQUEOUS COMPOSITIONS OF BORTEZOMIB | PSMG3, PSMA6, PSMA7 | LONP1 1892/4885PSMB5 13/4885PSMB8 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.